Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
Brufen 400mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. A white, pillow-shaped, film-coated tablet. |
Each Brufen tablet contains 400 mg of ibuprofen.
Excipient(s) with known effect: each tablet contains 26.7mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ibuprofen |
Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Blister pack comprising of transparent polyvinyl chloride (PVC) or polyvinyl chloride/polyvinylidene (PVC/PVDC) film with aluminium foil backing.
Pack size 60 tablets.
Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
PA2010/002/001
Date of first authorisation: 14 April 1975
Date of last renewal: 14 April 2010
| Drug | Countries | |
|---|---|---|
| BRUFEN | Albania, Austria, Australia, Cyprus, Estonia, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
